110results about How to "Reduce and prevent formation" patented technology

The invention relates to a cosmetic or dermatological composition containing a carrier comprising at least one fatty phase characterized in that it contains at least one derivative or a mixture of derivatives of 1,7-diphenyl-3,5-heptanedione having a particular structure and at least one oil having, in its structure, at least one amide unit.The invention also relates to its uses in cosmetics and dermatology, in particular for preventing or combating the harmful effects of UV radiation and pollution on human keratinous materials, and more particularly for preventing and / or treating photoaging of the skin.The invention also relates to a method for solubilizing a derivative or a mixture of derivatives of 1,7-diphenyl-3,5-heptanedione having a particular structure with at least one oil having, in its structure, at least one amide unit.

Disclosed herein are methods and compositions for treating or preventing Huntington's Disease.

The present invention relates to alkylglycoside-containing compositions and methods for increasing the stability, reducing the aggregation and immunogenicity, increasing the biological activity, and reducing or preventing fibrillar formation of a peptide, polypeptide, or variant thereof, for example insulin and Peptide T or analog thereof.

Compositions and methods for modulating a DNA repair process in vivo or in vitro are provided. One aspect of the disclosure provides a pharmaceutical composition including a DNA repair modulator. The DNA repair modulator includes, but is not limited to, compositions such as polypeptides, for example antibodies; modified polypeptides; and branched or unbranched aliphatic, cycloaliphatic, substituted aliphatic, aromatic hydrocarbons, or heterocyclic carbon-based compounds that associate with a DNA repair polypeptide, for example, DNA-PKcs.

A system and method are provided for preventing damage to the epidermis or other epithelial or non-target tissue during photodynamic therapy treatment. For example, an inhibiting radiation can be used to control formation of a photosensitizer from a precursor photosensitizer in the epidermis or epithelial tissue. Subsequent application of a treatment radiation can activate the photosensitizer to damage or destroy target sites while the non-target tissue remains substantially unaffected.

The present invention relates to compositions and methods employing a water soluble magnesium compound. In certain embodiments, the composition includes water and water soluble magnesium compound, but lacks other materials commonly used in cleaning compositions. The methods and compositions can provide magnesium ion at predefined ratios to calcium ion in water, such as magnesium ion in a molar amount equal to or in excess over a molar amount of calcium ion. A water soluble magnesium salt including an anion of a water soluble calcium salt is more effective than a magnesium salt with an anion of a water insoluble calcium salt. These compositions can be used for reducing lime scale or precipitate formation from hard water, removing soap scum, or the like.

The invention relates to structured water and its antioxidant activity. In addition, the present invention relates to antioxidants incorporated within the cluster structure of either electropositive (S water) or electronegative (I water). The structured water, having the antioxidant within its cluster structure, has a stabilizing effect on the antioxidant. In addition, the antioxidant activity inherent to structured water is enhanced by the presence of the antioxidant within its cluster structure. The present invention also includes methods of removing or reducing free radicals on the skin and thereby preventing the signs of skin aging and the risks of cancer associated with the presence of free radicals in the skin.

Vanes are used for reducing drag on a moving vehicle having a substantially planar rear surface. The current disclosure describes a means for mounting vanes to a vehicle using pliant material which creates no work for the driver of the vehicle during loading or unloading activities. The apparatus is extremely light weight, and includes a rigid vane of length L having a leading edge, a trailing edge, and an aerodynamic center therebetween, positioned at a distance of between 0.15 L and 0.5L from said leading edge. The vane has an inner surface facing the vehicle and an outer surface. At least one first pliant attachment means connects the leading edge of the vane to a side surface of said vehicle; at least one second pliant attachment means connects the inner surface of said vane to a rear surface of said vehicle; and a third pliant attachment means connects the trailing edge of the vane to the vehicle. The second pliant attachment means is connected to the inner surface of the vane at a distance of between 0.15 L and 0.5L from the leading edge of said vane; or at the aerodynamic center of the vane. The vane helps prevent or reduce formation of a zone of turbulent air behind the vehicle. The apparatus allows substantial reductions in fuel consumption and, as a result of the fuel savings, the invention also reduces truck CO2 emissions during use.

Provided herein is a placental membrane product comprising an immunocompatible chorionic membrane. Such placental membrane products can be cryopreserved and contain therapeutic factors and viable cells after thawing. The placental membrane products are useful in wound healing or tissue repair / regeneration as they are capable of promoting angiogenesis, reducing inflammation, reducing scar formation, and other methods that promote healing. The present technology relates to products to protect injured or damaged tissue, or as a covering to exclude bacteria, to inhibit bacterial activity, or to promote healing or growth of tissue. The field also relates to methods of manufacturing and methods of use of such membrane-derived products.

Provided herein is a placental membrane product comprising an immunocompatible amniotic membrane. Such placental membrane products can be cryopreserved and contain therapeutic factors and viable cells after thawing. The placental membrane products are useful in wound healing and tissue repair / regeneration as they are capable of promoting angiogenesis, reducing inflammation, inhibiting proteases and free radical oxidation, reducing scar formation, and other methods that promote healing. The present technology relates to products to protect injured or damaged tissue, or as a covering to prevent adhesions, to exclude bacteria, to inhibit bacterial activity, and / or to promote healing or growth of tissue. The field also relates to methods of manufacturing and methods of use of such membrane-derived products.

The invention is based on a correlation observed between visceral fat and gut flora. The invention relates to a product increasing the relative proportion of bifidobacteria in the intestines and to be used for preventing formation of visceral fat or for reducing the amount thereof in the body. In particular, the product increases the ratio of bifidobacteria to Clostridia. The invention also relates to determining visceral fat in the body by determining the relative proportion of bifidobacteria or Clostridia or their ratio to each other in the intestines. The invention further relates to a method for estimating, in the same manner, the health risk associated with obesity.

The present invention is directed towards a composition comprising, in an aqueous medium: (a) at least one anti-dandruff agent; (b) at least one viscosity modifying agent; (c) at least acrylic-based polymeric compound different from the viscosity modifying agent; (d) at least two surfactants chosen from amphoteric surfactants and zwitterionic surfactants; and (e) optionally, at least one conditioning agent. The present invention also relates to a process for the care of hair and / or scalp.

An ink composition comprising: a self-dispersing carbon black, a binder, a stabilizing dye comprising at least as many groups comprising CO2H or COSH as groups comprising SO3H, and an aqueous vehicle. The stabilizing dye can improve the reliability and performance of the ink composition. The addition of the stabilizing dye can reduce or prevent the formation of material that blocks the printhead vias and throats as a result of the presence of a binder in the ink. The ink composition can reduce the amount of maintenance needed to retain all of a printhead's nozzles through the life of the printhead.

A process for producing mesophase pitch using a long tube reactor is disclosed. An aromatic rich feed, preferably a petroleum pitch having a softening point above 100° C., is preheated to a temperature above its softening point and mixed with a vapor, preferably steam, in a long tubular reactor under intense mixing conditions, preferably fully developed turbulent flow such as mist annular flow, with a residence time at least an order of magnitude less than prior art processes and preferably less than 10 seconds. Preferably the reactor is heated by electric resistance or induction heating or by immersion in a heated fluid or in a fired heater. Mesophase pitch with a high coking value and a surprisingly low quinolone insoluble content is produced. The byproducts of thermal polymerization and thermal dealkylation have less than 50% as much olefin and diene content as compared to similar byproducts from prior art processes.

The present invention relates to the use of plasminogen / plasmin and its derivatives as agents for enhancing host defense against infection or other infectious diseases. The invention also relates to a method for screening of compounds which enhance host defense against infection by evaluating the host defense against bacterial arthritis and spontaneous otitis media in an animal model.

A process for passivating rare-earth alloy powders such that magnets formed from the powders have fewer expansion defects is described. By exposing the rare-earth alloy powders to a humid atmosphere, rare-earth oxide impurities that could result in eruptions in the magnets are reduced. Magnets made from the passivated powder show fewer expansion defects than magnets made from unpassivated powder.

The present invention provides synthetic immunogenic lipopeptide molecules comprising co-linear T-helper and B cell epitopes, and methods for their production and use in the generation of primary and secondary immune responses, and for the vaccination of animal subjects against particular antigens. More particularly, the present invention provides highly soluble lipopeptides wherein the lipid moiety is attached to the terminal side-chain group of an internal lysine or lysine analog, preferably to the terminal side-chain group of an internal diamino acid residue. Preferably the internal lysine or lysine analog is positioned between the T-helper epitope and the B cell epitope or within the T-helper epitope.

Disclosed are compositions and methods for their use that include a combination of hydrolyzed algin, escin, Ruscus aculeatus root extract, ammonium glycyrrhizate, Centella asiatica extract, hydrolyzed yeast protein, and Calendula officinalis flower extract.

An atomizing nozzle for two substances, which is used for spraying a liquid with the aid of a compressed gas, is provided. The atomizing nozzle includes a mixing chamber, a liquid inlet that extends into the mixing chamber, a compressed gas inlet which extends into the mixing chamber, and an outlet located downstream from the mixing chamber. An annular gap is provided which surrounds the outlet and discharges compressed gas at a high speed. The atomizing nozzle is used for purifying flue gas.

The invention relates to a stable pharmaceutical composition comprising comprising a solid dispersion of tacrolimus in a vehicle further comprising a stabilizing agent capable of providing a pH below 7 in the composition, as measured after re-dispersion in water, and preventing or reducing the formation upon storage of major degradation products of tacrolimus, in particular the 8-epitacrolimus.

Reducing or preventing adhesions which would form in a patient during or after surgery by administering to the wound surface of a patient a fibrinogen solution in an amount of about 0.025 ml fibrinogen / cm2 to about 0.25 ml fibrinogen / cm2 of the surface being at risk for developing adhesions. User of fibrinogen in a preparation comprising fibrinogen at a concentration of 20 to 80 mg / ml for the reduction or prevention of post-surgical adhesion formation.

A method for preventing the formation of contaminating polymeric films on the backsides of semiconductor substrates includes providing an oxygen-impregnated focus ring and / or an oxygen-impregnated chuck that releases oxygen during etching operations. The method further provides delivering oxygen gas to the substrate by mixing oxygen in the cooling gas mixture, maintaining the focus ring at a temperature no greater than the substrate temperature during etching and cleaning the substrate using a two step plasma cleaning sequence that includes suspending the substrate above the chuck.